These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1589723)

  • 21. In vitro evaluation of the synergistic antiviral effects of acemannan in combination with azidothymidine and acyclovir.
    Kahlon JB; Kemp MC; Yawei N; Carpenter RH; Shannon WM; McAnalley BH
    Mol Biother; 1991 Dec; 3(4):214-23. PubMed ID: 1662957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New AZT analogues having 5'-alkylsulfonyl groups: synthesis and anti-HIV activity.
    Al-Masoudi NA; Al-Soud YA; Ali IA; Schuppler T; Pannecouque C; De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(3):223-30. PubMed ID: 17454731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral effects of amphotericin B methyl ester.
    Jordan GW; Seet EC
    Antimicrob Agents Chemother; 1978 Feb; 13(2):199-204. PubMed ID: 206201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of recombinant CD4-immunoglobulin in combination with azidothymidine, dideoxyinosine and 0.5 beta-monoclonal antibody on human immunodeficiency virus infection in vitro.
    Ushijima H; Kunisada T; Kitamura T; Müller WE
    Lett Appl Microbiol; 1994 Jul; 19(1):1-5. PubMed ID: 7765215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nystatin, amphotericin B and amphotericin B methyl ester on Saccharomyces cerevisiae with different lipid composition.
    de Resende MA; Alterthum F
    Mycopathologia; 1990 Dec; 112(3):165-72. PubMed ID: 2089258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates].
    Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA
    Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.
    Cox SW; Albert J; Wahlberg J; Uhlén M; Wahren B
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1229-34. PubMed ID: 1520536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new nucleoside analogue.
    Torres G
    GMHC Treat Issues; 1995 Jun; 9(6):12. PubMed ID: 11362687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.
    Richman DD
    Am J Med; 1990 May; 88(5B):8S-10S. PubMed ID: 2186629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro susceptibility of yeasts to amphotericin B and three methyl ester derivatives.
    Oblack DL; Hewitt WL; Martin WJ
    Antimicrob Agents Chemother; 1981 Jan; 19(1):106-9. PubMed ID: 7247350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can combination therapy overcome drug resistance?
    Cohen J
    Science; 1993 May; 260(5112):1258. PubMed ID: 7684162
    [No Abstract]   [Full Text] [Related]  

  • 33. In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response.
    Edlin BR; St Clair MH; Pitha PM; Whaling SM; King DM; Bitran JD; Weinstein RA
    Ann Intern Med; 1992 Sep; 117(6):457-60. PubMed ID: 1503348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS.
    Land S; Terloar G; McPhee D; Birch C; Doherty R; Cooper D; Gust I
    J Infect Dis; 1990 Feb; 161(2):326-9. PubMed ID: 2299212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N, N, N-trimethylamphotericin B methyl ester chloride (DMS-AME): in vitro and in vivo antifungal activity studies in comparison with fungizone.
    Zaremba M; Borowski J; Feliński J; Rozkiewicz D; Rozkiewicz M; Zaremba K; Czerwiński A; Borowski E
    J Chemother; 1989 Jul; 1(4 Suppl):243-5. PubMed ID: 16312386
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
    Soltow SM; Brenner GM
    Antimicrob Agents Chemother; 2007 Jan; 51(1):23-7. PubMed ID: 17060522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of combinations of ampligen and zidovudine or dideoxyinosine against human immunodeficiency viruses in vitro.
    O'Marro SD; Armstrong JA; Asuncion C; Gueverra L; Ho M
    Antiviral Res; 1992 Feb; 17(2):169-77. PubMed ID: 1554239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease.
    Carter WA; Ventura D; Shapiro DE; Strayer DR; Gillespie DH; Hubbell HR
    Int J Immunopharmacol; 1991; 13 Suppl 1():69-76. PubMed ID: 1688087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus.
    Mitchell WM; Montefiori DC; Robinson WE; Strayer DR; Carter WA
    Lancet; 1987 Apr; 1(8538):890-2. PubMed ID: 2882293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.